Exploration of impact of tumor BRCA zygosity and genomic   loss-of-heterozygosity (gLOH) on efficacy in Phase 3 EMBRACA study of   talazoparib in patients (pts) with HER2-negative (HER2-) advanced breast   cancer (ABC) and a germline BRCA1/2 (gBRCA1/2) mutation

Document type:: Meeting Abstract
Author(s):: Litton, Jennifer K.; Laird, A. Douglas; Rugo, Hope S.; Ettl, Johannes; Hurvitz, Sara A.; Martin, Miguel; Roche, Henri; Im, Young-Hyuck; Goodwin, Annabel; Blum, Joanne L.; Eiermann, Wolfgang; Chen, Ying; Lanzalone, Silvana; Chelliserry, Jijumon; Czibere, Akos; Albacker, Lee A.; Frampton, Garrett M.; Mina, Lida A.
Title:: Exploration of impact of tumor BRCA zygosity and genomic loss-of-heterozygosity (gLOH) on efficacy in Phase 3 EMBRACA study of talazoparib in patients (pts) with HER2-negative (HER2-) advanced breast cancer (ABC) and a germline BRCA1/2 (gBRCA1/2) mutation
Journal title abbreviation:: Cancer Res
Year:: 2020
Journal volume:: 80 Suppl S
Journal issue:: 16
Fulltext / DOI:: doi:10.1158/1538-7445.AM2020-CT072
Print-ISSN:: 0008-5472
TUM Institution:: Frauenklinik und Poliklinik
BibTeX

Occurrences: